By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ritter Pharmaceuticals, Inc. 

1801 Century Park East
Suite 1820
Los Angeles  California  90067  U.S.A.
Phone: 310-203-1000 Fax: 310-919-1600


SEARCH JOBS


Industry
Pharmaceutical






Company News
FDA Digests Ritter Pharma's Phase II Microbiome Data 4/13/2017 12:18:53 PM
Tiny SoCal Pharma Ritter Pharma Hails A Mid-Stage Victory After Changing The Primary Endpoint And Recalculating Data Of Lactose Intolerance Drug 3/29/2017 7:02:13 AM
Ritter Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update 2/27/2017 9:30:42 AM
Ritter Pharmaceuticals, Inc. Announces Collaboration With University of British Columbia To Explore Development Of Microbiome Therapeutics In Environmental Enteropathy 2/14/2017 6:55:23 AM
Ritter Pharmaceuticals, Inc. To Ring Today's Nasdaq Stock Market Closing Bell To Kick-off Lactose Intolerance Awareness Month 1/31/2017 7:14:16 AM
Ritter Pharmaceuticals, Inc. Release: Company Announces Collaboration With University of Nebraska To Explore Development Of Microbiome Therapeutics In Metabolic Syndrome 1/23/2017 10:15:21 AM
Ritter Pharmaceuticals, Inc. Appoints William Merino, Ph.D., To Its Board Of Directors 1/17/2017 11:11:50 AM
Ritter Pharmaceuticals, Inc. Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published In PNAS 1/4/2017 10:27:47 AM
Ritter Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results And Provides Business Update 11/7/2016 12:51:36 PM
Ritter Pharmaceuticals, Inc. Prices $5,000,000 Public Offering Of Common Stock 10/26/2016 12:02:57 PM
12345
//-->